Trials / Sponsors / Hal Chapman
Hal Chapman
Academic / Other · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Collagen-targeted Positron Emission Tomography (PET) Imaging for Assessment of EGCG Effect Idiopathic Pulmonary Fibrosis | Phase 1 | 2024-02-07 |
| Completed | Study of Oral Epigallocatechin-3-gallate (EGCG) in IPF Patients Idiopathic Pulmonary Fibrosis | Phase 1 | 2023-08-24 |
| Completed | Fibroblast Specific Inhibition of LOXL2 and TGFbeta1 Signaling in Patients With Pulmonary Fibrosis. Idiopathic Pulmonary Fibrosis | EARLY_Phase 1 | 2017-12-01 |